Search for: "MAJOR PHARMACEUTICALS" Results 461 - 480 of 4,373
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Jan 2022, 11:45 am by luiza
Here are the top ten healthcare recoveries of 2021 by the numbers: Generic Drug Price-Fixing – in October, three generic pharmaceutical manufacturers, Taro Pharmaceuticals USA, Inc., Sandoz and Apotex Corporation, agreed to pay $447.2 million to resolve alleged violations of the False Claims Act arising from conspiracies to fix the price of various generic drugs. [read post]
11 Jan 2022, 11:45 am by luiza
Here are the top ten healthcare recoveries of 2021 by the numbers: Generic Drug Price-Fixing – in October, three generic pharmaceutical manufacturers, Taro Pharmaceuticals USA, Inc., Sandoz and Apotex Corporation, agreed to pay $447.2 million to resolve alleged violations of the False Claims Act arising from conspiracies to fix the price of various generic drugs. [read post]
6 Jan 2022, 1:22 pm by Kevin LaCroix
Judge Borrock also cited the “internal affairs” doctrine, noting that Germany has a significant interest in regulating a major German corporation governed by German law. [read post]
4 Jan 2022, 12:00 am by Kurt R. Karst
We summarized the major revisions to the Code in a blog post when it was released in August 2021. [read post]
2 Jan 2022, 7:24 am by Kevin LaCroix
However, the vast majority of suits were filed in federal courts in California and in New York. [read post]
28 Dec 2021, 5:01 am by Jacob N. Shapiro, Alicia Wanless
Right now, the major platforms’ consumer-facing notion of trust and safety is the main lens through which the information environment is viewed. [read post]
21 Dec 2021, 9:33 am by Bob Ambrogi
  A computer scientist by training, Balachandran founded Exterro in 2008, quickly convincing a Fortune 100 pharmaceutical company to sign on as his first customer. [read post]
21 Dec 2021, 9:33 am by Bob Ambrogi
  A computer scientist by training, Balachandran founded Exterro in 2008, quickly convincing a Fortune 100 pharmaceutical company to sign on as his first customer. [read post]
21 Dec 2021, 9:21 am by Populus Radio, Robert Ambrogi
    A computer scientist by training, Balachandran founded Exterro in 2008, quickly convincing a Fortune 100 pharmaceutical company to sign on as his first customer. [read post]
20 Dec 2021, 4:15 am by Steve Brachmann
Several breakthrough COVID-19 vaccines have been developed by major R&D firms in the pharmaceutical sector, and despite some myopic posturing by several global leaders, a waiver of international IP obligations under the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) has not materialized, ensuring that R&D leaders are... [read post]
20 Dec 2021, 4:15 am by Steve Brachmann
Several breakthrough COVID-19 vaccines have been developed by major R&D firms in the pharmaceutical sector, and despite some myopic posturing by several global leaders, a waiver of international IP obligations under the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) has not materialized, ensuring that R&D leaders are properly incentivized to continue pursuing advanced treatments and vaccines for new variants like omicron. [read post]
  The FTC had requested comment on “all major provisions of the COPPA Rule, including its definitions, notice and parental-consent requirements, exceptions to verifiable parental consent, and safe-harbor provision. [read post]
15 Dec 2021, 11:26 am by Alden Abbott
In issuing its regulatory wish list, the FTC’s current “majority” (actually, only two of the four sitting members) pay no heed to spirited dissents by Commissioners Christine S. [read post]
9 Dec 2021, 11:02 am by Tom Lamb
These black boxes now highlight the higher rate of major adverse cardiac events seen versus anti-TNF agents in the Oral Surveillance trial of Xeljanz. [read post]
9 Dec 2021, 7:15 am by Logan Murr
Judge Taranto partially dissented from the majority’s judgment on claim construction/ infringement. [read post]